Boys' Use of Gardasil Is Approved
October 20, 2009
On Friday, the Food and Drug Administration approved Merck & Co.'s human papillomavirus vaccine Gardasil as safe and effective at protecting males from genital warts caused by HPV types 6 and 11. FDA approved the vaccine's use by males ages 9-26. Gardasil is already approved for use by females ages 9-26 to prevent cervical, vulvar and vaginal cancer, precancerous lesions, and genital warts.
Wall Street Journal
10.17.2009; Jonathan D. Rockoff
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.